Author: therawinformant

The share price of Australia’s largest debt-collector, Credit Corp Group Limited (ASX: CCP) has surged by 13.4% today prior to being sold down to a more modest gain of 9.4%. The Credit Corp share price rallied as high as $19.10 before falling back to $18.43 at the time of writing. The surge came following the company’s announcement of its FY20 results. 

Credit Corp has clawed its way back from a $6.25 low in March this year, yet still faces an uphill battle returning to its 52-week high price of almost $38 seen in February. This may present an opportunity too good to miss for prospective investors wishing to take advantage of this 51% discount to the company’s share price highs.

So why were this morning’s results so well received and is now the time to dive in and invest in the Credit Corp share price?

Credit Corp FY20 results  

The business model of a debt corporation like Credit Corp has been one of the beneficiaries of COVID-19 as liquidity in the marketplace has dried up and many businesses have struggled in the repayment of debts. This company is commonly outsourced to recover debts on behalf of banks, telecommunications providers and utility companies at a discount.

In its announcement to the market this morning, Credit Corp reported a 13% improvement in Net Profit After Tax (NPAT) before adjustments of $79.6 million. In addition, the company’s total revenues for the period were marginally lower at $313 million compared to FY19 sales of $324 million. In accounting for these lower revenues, the company cited that COVID-19 economic uncertainty had meant customers were less willing to agree to longer-term debt repayment plans from March onwards.

Yet, this trend was somewhat offset by an improvement in one-off customer payments in May and June, possibly spurred by government benefits such as JobKeeper and people paying off debts with their FY20 tax returns.

The federal government’s announcement last week that it would be extending coronavirus-related fiscal stimulus through to March 2021 is a potential tailwind for Credit Corp. Further cash in people’s pockets will enable them to prioritise debt repayments.  

Overall, therefore, Credit Corp remains optimistic that it can achieve further profitability in FY21 and provided guidance of between $60 and $75 million for NPAT, an earnings per share (EPS) range of 89-112 cents, and a dividend range of 45-55 cents per share. If achieved, this could yield a 2.7% fully-franked return to shareholders over FY21. This represents a relatively sizeable payout in the current economic environment.

The company has also appeared to strengthen its balance sheet over the second-half of FY20, aided by an equity raising of $152 million and over $400 million in cash. In a twist of irony, the company’s announcement also highlighted that Credit Corp itself is effectively now ‘debt-free’, a feat the company believes will enable it to ‘facilitate continued purchasing and lending over an extended period of uncertainty and prepare for opportunity’.

Should you invest?

Looking forward to the coming 12 months, I think Credit Corp will profoundly benefit from lingering liquidity issues in Australian businesses and broader commerce. The fact that Australia technically entered a recession (2 quarters of negative GDP growth) in June this year, coupled with a second-wave of COVID-19 rapidly advancing across our borders, spells trouble for businesses.

Recessions are generally associated with businesses defaulting on loans and closing their doors, and experts agree it is going to take an avalanche of continued government stimulus to keep small businesses on life support in perpetuity.

Whilst this is obviously not good news for business and the economy overall, I do see a lot of potential for Credit Corp’s debt book to grow over the next year. Particularly as clients like the big four banks are forced to outsource debt to third parties. The company has bolstered its balance sheet and has done extraordinarily well to maintain a profit over FY20 considering the circumstances. Keep an eye on the Credit Corp share price to continue performing strongly in the coming months, particularly if domestic economic conditions remain as volatile as they are now.  

More reading

• ASX 200 jumps 0.75%: Westpac tumbles on AUSTRAC update, Credit Corp surges
• Why Credit Corp, Nufarm, Regis, & Temple & Webster shares are jumping higher
• 5 things to watch on the ASX 200 on Tuesday
• Top brokers list the latest ASX small cap stocks to buy today
• 5 top performing ASX 200 shares from last week

Motley Fool contributor Toby Thomas does not hold shares in Credit Corp Group Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Credit Corp share price jumps 13%, should you invest? appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/3jM8Hw8

Investment platform provider CommSec has just released data on the five most traded ASX shares on its platform from last week.

Once again, the buy now pay later sector was popular with investors and accounted for three of the top five shares.

They were joined by two healthcare shares – one industry giant and one name that many investors will not have come across before.

Here’s the data:

Zip Co Ltd (ASX: Z1P)

For a second week in a row, Zip shares were the most traded on the ASX by CommSec customers. The buy now pay later company’s shares accounted for 3.2% of total trades made on the CommSec platform. Although the buying and selling was relatively even over the period, it didn’t stop the Zip share price from pushing 8.1% higher.

Afterpay Ltd (ASX: APT)

The Afterpay share price was popular with investors again. Its shares accounted for 2.2% of all CommSec trades last week. Approximately 53% of these trades were sell orders, possibly due to concerns over Shopify’s buy now pay later launch. However, despite this, the Afterpay share price was able to carve out a 3.6% gain last week.

CSL Limited (ASX: CSL)

CommSec customers were buying this biotherapeutics company’s shares last week by the boatload. CSL accounted for 2% of all trades by CommSec customers last week, with almost 80% of these trades reported as buy orders. Though, this couldn’t stop the company’s shares from recording a decline of 4% over the period. Investors appear divided on whether its FY 2021 earnings will be impacted materially by lower plasma collections.

Immuron Limited (ASX: IMC)

This biotech company’s shares were on fire last week and more than doubled in value after its study indicated that IMM-124E therapy had neutralising activity against the severe acute respiratory syndrome coronavirus-2. This is the virus that causes COVID-19. Immuron’s shares accounted for 2% of all trades on the CommSec platform.

Openpay Group Ltd (ASX: OPY)

Finally, junior buy now pay later provider Openpay made the list again. It was responsible for 1.7% of total trades on the CommSec platform last week. This was despite there being no news out of the company. However, a week earlier it reported a 98.2% increase in total transaction value to $192.8 million for FY 2020. The Openpay share price recorded a 5.3% gain for the week

More reading

• Latest ASX entrant mixes BNPL with eCommerce
• Is CommBank the BNPL killer?
• Is it finally time to buy at today’s CSL share price?
• 3 Warren Buffett quotes to start the week off right
• Why these brokers are telling you to buy the crashing IAG share price today

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. and ZIPCOLTD FPO. The Motley Fool Australia owns shares of AFTERPAY T FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Afterpay and Immuron were among the most traded shares on the ASX last week appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/3f7QJk7

This morning, the Iluka Resources Limited (ASX: ILU) share price rose 1.24% to $9.42 following the release of the company’s quarterly review. The Iluka share price has since retreated slightly to sit at $9.35 per share at the time of writing, up 0.54% on yesterday’s close

What was in the announcement?

Illuka reported total zircon, rutile and synthetic rutile production of 135,000 tonnes in the quarter ended June 2020. Iluka’s Zircon production was down 16% compared to the first quarter of the year, as the company intentionally reduced production due to economic uncertainty.

The company’s rutile production was down 29% compared to the first quarter of the year, due to lower run time and throughput at the company’s Sierra rutile asset. Synthetic rutile production was up 10%, which the company attributed to higher ilmenite quality and plant upgrades.

Iluka sold 242,000 tonnes of zircon, rutile and synthetic rutile during the first half of 2020, a reduction of 19.87% compared to the first half of 2019 when the company sold 302,000 tonnes of the same materials.

The company sold 53,000 tonnes of zircon in the second quarter of 2020 compared to 25,000 tonnes in the first quarter of the year, however, sales were affected by the impacts of the coronavirus pandemic on Chinese and European markets. 

Iluka sold 66,000 tonnes of titanium in the second quarter of 2020, compared to 98,000 tonnes in the first quarter. The company announced that rutile prices were up 7% since the first half of 2019. It also announced that Zircon prices fell 6% in the first half of 2020.

Iluka also announced that it had completed commissioning of its Eneabba operation during the quarter, with 9,000 tonnes of monazite-zircon concentrate material shipped ahead of schedule.

The company had net cash of $62 million at 30 June 2020. It had free cash flow of $46 million in the first half of 2020, and invested $50 million into capital expenditure. 

Iluka also announced that all mining and processing sites were operational in the current environment.

About the Iluka share price

Iluka is an Australian-based resources company that explores and develops mineral sands assets. The company is the world’s largest producer of zircon, titanium-based rutile and synthetic rutile.

In June, Iluka announced that one of its customers had defaulted on its obligation to take and pay for 20,000 tonnes of synthetic rutile. Proceedings have since been made by Iluka in the Supreme Court in the state of New York.

The Iluka share price is up 63.46% since its 52-week low of $5.72. It has risen 1.52% since the beginning of the year. The Iluka share price is down 1.3% since this time last year.

More reading

• Where to invest $500 into ASX shares immediately
• Top broker warns earnings expectations for the ASX reporting season are too high
• Credit Corp share price jumps 13%, should you invest?
• Afterpay and Immuron were among the most traded shares on the ASX last week
• Why PolyNovo and these ASX healthcare shares could be long term market beaters

Motley Fool contributor Chris Chitty has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Iluka share price rises after quarterly review appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2P2Ku6E

I think the healthcare sector is a great place to invest with a long term view due to the favourable tailwinds that it is experiencing.

These include ageing populations around the globe, increased chronic disease burden, and better technologies. But with so many options for investors to choose from, which ones should you be buying?

Below are three ASX healthcare shares I believe could provide stellar returns for investors over the long term:

Nanosonics Ltd (ASX: NAN)

The first healthcare share to consider buying is Nanosonics. It is an infection prevention specialist best known for its trophon EPR disinfection system for ultrasound probes. It is also the first high level disinfection system for ultrasound probes that is effective against high-risk, cancer causing strains of Human Papilloma Virus. This has gone down very well with healthcare institutions, leading to its installed base growing at a rapid rate over the last few years. The good news is that there’s still a large addressable market for it to grow into in the coming years. This should be supported by the launch of new products targeting unmet needs which have similar market opportunities. If they are anywhere near as successful, Nanosonics will have a very bright future ahead of it.

PolyNovo Ltd (ASX: PNV)

Another healthcare share which I think could have a bright future ahead of it is PolyNovo. It is the medical device company behind the NovoSorb Biodegradable Temporising Matrix (BTM) product. This synthetic polymer was developed at CSIRO and is used by clinicians to treat serious burn and skin trauma patients. It can be used in surgical procedures and will eventually biodegrade safely and be excreted by the body. The company’s current target market has a sizeable $1.5 billion addressable opportunity. However, management is looking to expand BTM’s use into the hernia and breast treatment markets. This would lift its addressable market to a total of $7.5 billion if successful.

Ramsay Health Care Limited (ASX: RHC)

A final healthcare share to look at is Ramsay Health Care. This global private hospital operator currently has 480 facilities across 11 countries. Although the near future is not going to be easy for Ramsay due to both the pandemic and general tough trading conditions in the private hospital space, I believe its long term outlook is very positive. This could make it worth considering a long term and patient investment in its shares. Especially given the aforementioned tailwinds that the sector is experiencing. This is likely to lead to a strong increase in demand for its services over the next decade and beyond.

More reading

• Leading brokers name 3 ASX shares to sell today
• 3 junior ASX healthcare shares with explosive growth potential
• These ASX shares could be great additions to a retirement portfolio
• Here are easy ways to diversify your ASX portfolio
• Why I would buy Ramsay and this ASX blue chip share

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Nanosonics Limited and POLYNOVO FPO. The Motley Fool Australia has recommended Nanosonics Limited and Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Why PolyNovo and these ASX healthcare shares could be long term market beaters appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2BAumpE

If you are looking for some ASX share suggestions,  I believe that the following 2 companies are well worth considering.

Both Pushpay Holdings Ltd (ASX: PPH) and Macquarie Telecom Group Ltd (ASX: MAQ) have seen very strong share price gains over the last 6 months, driven by their impressive recent financial performances.

Macquarie Telecom

Macquarie Telecom has continued to grow at a rate well ahead of some of its larger telco rivals such as Telstra Corporation Ltd (ASX: TLS).

For the 6 months ended 31 December, Macquarie delivered a 9% rise in revenue on the prior corresponding period. The telco’s earnings before interest, tax, depreciation and amortisation (EBITDA) grew even more strongly, by 24% in the first half. The main driver of this growth was the company’s hosting business, which offers cloud computing-related services including data centre services. This division reported an 18% increase in revenue to $62.7 million. 

This strong revenue growth is reflected in Macquarie Telecom’s recent share price growth. The Macquarie Telecom share price has risen from $23.21 at the beginning of 2020 to now be trading at $46.25.

Macquarie Telecom has also indicated it will continue to invest in and drive growth from 3 key megatrends: data centres, cloud computing and cyber security. These 3 market segments are now driving growth in IT markets worldwide.

The local Australian telco is particularly focused on capturing the growing demand for data centre services through the expansion of its data centre portfolio. Earlier this year, the company commenced construction of its IC3 East data centre at the Macquarie Park Data Centre Campus. This expansion will help to meet the growing demand from its corporate, wholesale, and government customers.

Pushpay

Pushpay offers a donor management platform provider for the faith, not-for-profit, and education sectors. The company operates in the large-to-medium church sector of the massive US market.

After trending sideways since the beginning of 2018, the Pushpay share price has been on fire in recent months. The company’s share price has risen from $2.94 in late March to now be trading at $7.54. That’s a gain of 156%. Its share price did reach as high as $8.90 in late June, but has since lost some of those gains in recent weeks.

This share price growth comes on the back of strong recent expansion in its customer base. Pushpay achieved an impressive 39% increase in its total processing volume to US$5 billion for the 12 months to 31 March 2020.

I believe that Pushpay is well positioned for continued growth, driven by the growing demand for its donor management platform in the large (and mainly untapped) US market.

Foolish takeaway

Both Macquarie Telecom and Pushpay operate in two very different markets. However, both are quality companies and I am confident that both have strong growth prospects over the next few years.

More reading

• Why Telstra is a top ASX dividend share to buy in August
• Why I would buy Pushpay and these ASX growth shares in August
• These shares were the ASX 200’s biggest losers last week
• ASX 200 Weekly Wrap: ASX has week of high volatility
• Replace your term deposit with these ASX dividend shares

Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of PUSHPAY FPO NZX. The Motley Fool Australia has recommended PUSHPAY FPO NZX. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Pushpay and 1 other 5-star ASX share to buy right now appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2CK7gh3

The Chesser Resources Limited (ASX: CHZ) share price has bolted more than 180% higher in today’s trade after the company reported spectacular drilling results from its Gold Project in West Africa.

Highlights from Chesser’s drilling report

Earlier today, Chesser reported drilling results from its flagship Diamba Sud gold project in Senegal, West Africa. The company’s drill results were from 17 reverse circulation (RC) holes, with 9 holes coming from Area D, 4 holes from Area B and the remaining 4 holes from the Western Splay area.

Chesser reported high-grade intersections of up to 67.80 grams per tonne (g/t) gold within Area D. The best results from this area included: 48 metres at 6.70 g/t gold from 24 metres, including 10 metres at 25.14 g/t gold from 62 metres; and 55 metres at 4.27 g/t gold from 16 metres.

Chesser also reported promising results from the Western Splay area with significant intersections including: 2 metres at 19.80 g/t gold from 4 metres; 6 metres at 1.79 g/t gold from 28 metres; and 10 metres at 1.10 g/t gold from 111 metres. The company also noted positive results from Area B, with mineralisation noted in hole DSR162 and intersected 10 metres at 1.26 g/t gold from 50 metres and one metre at 3.44 g/t gold from 89 metres.

The company’s management noted the exceptional and rare high grade, consistency and thickness of the drilling results. Chesser also informed investors that results from 6 holes in Area A are pending and assured shareholders of the company’s strong cash balance.

Background on Chesser Resources

Chesser Resources is a listed gold exploration company with projects located in Senegal, West Africa. The company’s flagship Diamba Sud project is expected to host numerous multimillion-ounce gold deposits. Earlier this month the company completed a $6 million capital raising in order to fund the large-scale drilling at the Diamba Sud project.

Foolish takeaway

The Chesser share price soared more than 180% higher in early trade, hitting an intra-day high of 30.5 cents. At the time of writing the company’s shares have dipped to 30 cents, up 180.95% for the day.

More reading

• Why PolyNovo and these ASX healthcare shares could be long term market beaters
• Pushpay and 1 other 5-star ASX share to buy right now
• Leading brokers name 3 ASX shares to sell today
• Don’t be blinded by gold fever…consider these ASX dividend shares instead
• Latest ASX entrant mixes BNPL with eCommerce

Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Chesser Resources share price blasts 180% higher on drill results appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2OYyMd2

On Monday I looked at three ASX shares that brokers have given buy ratings to this week.

Unfortunately, not all shares are in favour with them right now. Three that have just been given sell ratings are listed below.

Here’s why these brokers are bearish on these ASX shares:

Ramsay Health Care Limited (ASX: RHC)

According to a note out Morgan Stanley, its analysts have retained their underweight rating but lifted their price target on this private hospital operator’s shares slightly to $56.00. Morgan Stanley has been looking into elective surgeries and notes that rates had recovered to 75% of pre-pandemic levels at the end of June (excluding Victoria). While this is a positive and it expects Ramsay’s utilisation rates to be solid during the first half of FY 2021, it continues to have concerns over private health insurance affordability issues. Especially given the prospect of high unemployment levels. The Ramsay share price is changing hands for $62.32 this afternoon.

Reece Ltd (ASX: REH)

Analysts at Citi have downgraded this plumbing parts company’s shares to a sell rating with a reduced price target of $8.55. According to the note, the broker expects the pandemic to result in tough trading conditions that stifle its earnings growth over the next couple of years. Particularly given the weakening housing market activity and softening house prices. The Reece share price is trading at $9.79 on Tuesday.

South32 Ltd (ASX: S32)

A note out of the Macquarie equities desk reveals that its analysts have retained their underperform rating and $1.80 price target on this mining giant’s shares. Although the broker notes that South32 has exposure to the strengthening silver price, it remains concerned that weak coal and manganese prices will offset this and weigh on its earnings. In light of this, it sees no reason to change its rating at this point. The South32 share price is changing hands at $2.23 this afternoon.

More reading

• Why PolyNovo and these ASX healthcare shares could be long term market beaters
• These ASX shares could be great additions to a retirement portfolio
• Here are easy ways to diversify your ASX portfolio
• Why I would buy Ramsay and this ASX blue chip share
• The ASX sector that’s heading for a V-shape recovery

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Leading brokers name 3 ASX shares to sell today appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2X4fXJR

The financial headlines today are awash with gold.

You’ve likely already been inundated with that news, so I’ll keep this part brief.

The yellow metal hit an all-time high in US dollars overnight. At time of writing it’s trading for US$1,962 (AU$2,725) per troy ounce.

Gold’s current bull run is being driven by record low interest rates, ballooning government debts, and growing geopolitical uncertainty surrounding western relations with China. And, of course, the insecurity thrown up by the COVID-19 pandemic.

In short, a cornucopia of tailwinds is seeing retail and institutional investors — not to mention major central banks — add to their gold holdings. Some of that is in the form of physical bullion, though many retail investors are turning to gold exchange-traded funds (ETFs).

As you’d expect, this has seen the share price of most gold miners rocket.

Northern Star Resources Ltd (ASX: NST), for example, is up 44.3% so far in 2020.

And gold mining giant Newcrest Mining Limited (ASX: NCM), with a market cap of $30.4 billion, has gained 24.8% year to date.

Both shares are up in intraday trading today as well.

Should you jump on the gold bandwagon?

It’s tempting to buy gold and gold shares following a new wave of good news. But as the old investor adage goes, ‘If it’s in the news, it’s in the price’.

That doesn’t mean gold, and the companies that mine it, can’t go higher from here. But with greed abounding, it brings up unpleasant memories of bitcoin in the latter months of 2017. That greed saw the cryptocurrency soar to unprecedented heights before crashing hard in 2018.

At the moment, most analysts — and everyone I spoke to at last weekend’s barbecue — are greedy for a piece of the gold profits.

But as legendary value investor Warren Buffett advises, you should be, “fearful when others are greedy, and greedy when others are fearful.”

Noting that equities outperform gold over time, Buffett has also labelled investors buying gold when the price is rising as ‘foolish’. Of course that’s foolish without the capital F!

While I don’t expect gold to fall by more than 80%, like bitcoin did, it may well be approaching its peak. And I certainly wouldn’t rule out a fall of 10% or more from the current price.

That means gold miners’ share prices will again be determined by how much and how affordably they can dig the yellow metal from the ground. And not by a lot of hype over its new record prices.

A Foolish alternative

If you don’t have a high appetite for risk and aren’t comfortable jumping in and out of ASX shares, you’re probably better off turning your attention to yield shares.

These are shares that pay regular dividends. And if you invest in the right ones, you’ll ideally see their share prices rise as well.

Sydney-based Kardinia Capital has increased its exposure to ASX dividend shares. And the fund has an admirable track record. Since launching in May 2006, the Bennelong Kardinia Absolute Return Fund has an annualised return of 8.36%.

As quoted by Bloomberg, co-founder and portfolio manager Kristiaan Rehder said, “We are not just looking at companies that offer an attractive yield, we are also looking for companies that have a sustainable dividend yield. They are both important.”

Rehder went on to explain the fund is going beyond the traditional ASX dividend shares, like Atlas Arteria Group (ASX: ALX). It also holds JB Hi-Fi Limited (ASX: JBH) and Fortescue Metals Group Limited (ASX: FMG). He likes these shares because, “they offer heightened dividends with relative certainty of payouts due to resilient and strong earnings.”

If you’re looking to add an ASX dividend paying share to your portfolio, you may want to consider Collins Foods Ltd (ASX: CKF).

With a market capitalisation of $1.15 billion, the company is a KFC franchisee in Australia, the Netherlands and Germany. It’s also a Taco Bell franchisee in Australia and Sizzler franchisee in Asia. Collins is the owner of Sizzler restaurants in Australia.

In its annual results, released in June, Collins’ final dividend remained flat at 10.5 cents per share. That works out to a trailing yield of 2.1%, fully franked, meaning you can deduct the corporate tax rate from any taxes you may owe. Or even get some money back from the ATO depending on your personal financial situation.

Like most ASX shares, the Collins Foods share price tumbled from late February into mid-March. But it’s since rebounded strongly. From its low on 23 March, Collins’ shares are up 127.8%. Year-to-date the share price is up 11.1%.

As for gold fever? Avert your eyes.

More reading

• 3 ASX shares to cash in on the record high gold price
• 5 things to watch on the ASX 200 on Tuesday
• ASX 200 up 0.25%: Lynas rockets on U.S. deal, gold miners surge, bank shares tumble
• Why Lynas, Northern Star, REA Group, & Sezzle shares are storming higher
• JB HiFi and 1 other quality ASX share to buy right now

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Collins Foods Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Don’t be blinded by gold fever…consider these ASX dividend shares instead appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/30WWOKY